Pre-call brief · 30 July 2026
A GPhC-registered UK pharmacy running 67 live Meta ads — 23 unique creatives, one layout, and about seventy percent of them arguing the same point.
Who you're talking to
Tom Wallace, co-founder of Curate Health since July 2022. Before that he founded Vitamist (oral-spray supplements — Amazon, Boots, Revital, Lloyds), co-founded Monbelle (acquired), and held a shareholding in Vision Healthcare NV. So: a supplements-and-retail operator who has moved into regulated telehealth. He has sold a company and he has sold through Boots. He will not need the category explained to him.
That shapes the call. He knows distribution and he knows margin. What he is buying, if he buys, is creative throughput and a funnel layer he doesn't currently have — not education.
What the paid account actually looks like
Live ads
67
Active in GB, Meta Ad Library, 29 Jul
Unique creatives
23
By perceptual hash — the rest are duplicates across placements
Distinct layouts
1
Logo top-left, category pill top-right, headline, product, button bottom-left
Landing pages
2
61 of 67 ads route to /landing-1 or /landing-2
The headline finding isn't the ad count — it's that 23 creatives are 23 copy swaps inside one template. Same skeleton, same green, same weight of type, same button in the same corner. In a feed that reads as one ad shown twenty-three times.
Their live creative
Four of the 23. Full set: ~/marcin-co-ceo/research/curate-health-active-full/
Angle concentration
Price is a real angle and it is clearly working for them — it is not the problem. The problem is that it's the only angle, and price is the one axis where a competitor can undercut you on a Tuesday afternoon. There's no second thing holding the account up.
Worth noting: their own /weight-loss page opens with “Weight is shaped by your biology, health history and lifestyle — not willpower alone.” That's a mechanism angle, it's good, and not one ad uses it.
The funnel, end to end
1 · Ad
Green brand static. Price hook. “Learn more”.
2 · Dead click
/landing-1/age — a page that says “confirm you're 18 or over” and has one button. No verification. No persuasion.
3 · Lander
/landing-1 — BMI calculator, price table, testimonials, team, FAQ.
4 · Consult
5-minute questionnaire, clinician reviews within 48h.
Step 2 is the whole opportunity. Every pound of their paid traffic passes through a page that does nothing except collect a click. It's there for cover, and it's doing no selling.
Meanwhile they've built 47 articles at /health-hub across all five of their categories — genuinely decent SEO content — and zero paid traffic touches any of it. They already own the raw material for an editorial layer. They just never put it in the paid path.
Worth raising, carefully
A question for their compliance lead, not a legal opinion
UK CAP rule 12.12 bans advertising prescription-only medicines to the public. The ASA is running a joint enforcement sweep with the MHRA and the GPhC and has already actioned nine advertisers in this exact category. The published guidance specifically names, as breaches: discount codes and short-term promotional offers on POMs, limited-time urgency, POM-linked price claims, and “weight loss treatments” where the landing page implies a POM will be prescribed.
Their live ads currently carry WELCOME35 (in 98 of the ads I pulled), FBTR404,
FBWP10, “£40 OFF SITEWIDE – Ends Soon 🔥”, “from £98”,
“£3.13 a day” — and route to a page that names Mounjaro and Wegovy.
They're a registered pharmacy, so the GPhC can act on their registration, not just their ad account. Don't play lawyer. Ask how they're handling it — it shows you understand their world, and it makes the case for an editorial layer that can carry the argument without the ad having to do it.
What the competition is doing
| Curate | Voy | Numan | |
|---|---|---|---|
| Lead angle | Price, ~70% | “Not willpower, biology” | “If needles stopped you starting” |
| Creator lane | None | 9+ named partner pages, incl. Coleen Nolan | None visible |
| Advertorial | None | First-person celebrity story page | None visible |
| Lander split | One family, no segmentation | TOF / BOF × men / women / mums | Per treatment form |
| Lead proof | 4.8/5, 2,400+ reviews | 4.7/5, 20,918 reviews | 4.5/5, 30,000+ reviews |
| Risk reversal | None | Lose 10% body weight or money back | None visible |
Voy is the one to point at. They're running a structurally different game — nine creator handles posting paid partnership ads, a first-person celebrity advertorial as their single most-run destination, and landing pages split by funnel stage and audience. Curate is competing against that with one template and a price.
Something to put on the screen
Eight statics, built today. Deliberately on their own strongest angles — price, no-subscription, switching — using only numbers published on their own site and in their own ad copy. The point isn't new messaging. The point is that the same argument has eight different visual grammars available to it, and they're using one.
All eight are built to the UK rules: no drug names, no “GLP-1”, no pens or vials, no before-and-afters, no weight claims.
Built from builds/curate-fable-v1/. Substitute display face (Outfit) stands in for their licensed F37 Ginger. No packaging rendered — we don't have their asset pack, and we don't invent product.
What to say
Questions worth asking him